Is there cross‑reactivity between morphine and codeine in patients with a known morphine allergy or tolerance?

Morphine and Codeine Cross-Reactivity

Yes, morphine and codeine can cross-react in patients with true allergies, but clinically significant cross-reactivity is extremely rare, and most documented "opioid allergies" are actually intolerances or side effects rather than true IgE-mediated allergic reactions.

Understanding the Relationship

Codeine and morphine share a nearly identical chemical structure—both are natural opioids (phenanthrene alkaloids) with a 6-hydroxy group in the equatorial position 1. Codeine is actually a prodrug that requires metabolism by CYP2D6 to morphine for its analgesic effect 2. This structural similarity theoretically allows for cross-reactivity in true allergic reactions.

However, the critical clinical reality is that genuine IgE-mediated allergies to opioids are exceptionally rare 3. The vast majority of documented "opioid allergies" represent:

• Side effects (nausea, constipation, sedation)
• Histamine-mediated pseudo-allergic reactions (pruritus, flushing)
• Intolerances

Clinical Evidence on Cross-Reactivity

The most robust recent evidence shows minimal to no clinically significant cross-reactivity:

• A 2025 retrospective study of 1,507 patients with documented opioid allergies found 0% cross-reactivity across all opioid classes, with 100% tolerance rates on re-exposure 4
• A 2019 study of 499 hospitalized patients showed cross-reactivity rates of only 0-6.7%, with 92.5% successfully tolerating opioid readministration despite chart-documented allergies 5
• Importantly, 50% of historically documented "allergies" were actually intolerances 5

Practical Clinical Approach

For patients with documented morphine "allergy":

1. Determine if true allergy exists:

   • True IgE-mediated reactions: anaphylaxis, urticaria, angioedema, bronchospasm
   • NOT allergies: nausea, vomiting, constipation, pruritus alone, sedation

2. If true allergy to morphine is confirmed:

   • Avoid codeine due to structural similarity and metabolic conversion to morphine 1
   • Switch to alternative opioids: hydromorphone, oxymorphone, or fentanyl 2
   • These alternatives are recommended specifically for CYP2D6 poor metabolizers unable to use codeine 2

3. If documented reaction was intolerance/side effect:

   • Codeine can be used, though it may produce similar side effects
   • Consider that codeine effectiveness varies with CYP2D6 polymorphism 6, 2

Important Caveats

Do not rely on serological testing alone: Positive IgE to poppy seed or morphine does not predict clinical reactivity—a 2015 study showed 0/22 patients with positive IgE tests had reactions on controlled challenge 7. Oral provocation testing is needed for definitive diagnosis.

Beware of alert fatigue: Opioid allergy warnings often propagate unnecessary prescribing restrictions 5. Many patients (42-50%) with documented oxycodone allergies still receive the same opioid without incident 8.

The structural relationship matters: The 1980 case series demonstrated that the 6-hydroxy group in equatorial position (present in both morphine and codeine) is the antigenic determinant in rare true allergies 1. This supports theoretical cross-reactivity, but clinical manifestation remains exceedingly uncommon.

Bottom Line Algorithm

• True anaphylaxis/IgE-mediated reaction to morphine → Avoid codeine; use hydromorphone, oxymorphone, or fentanyl 2
• Side effects/intolerance to morphine → Codeine can be used but may cause similar issues; consider alternatives based on CYP2D6 status 2
• Uncertain history → Consider supervised challenge or use structurally dissimilar opioid (fentanyl, methadone) 2

The FDA label for morphine lists hypersensitivity as a contraindication 9, but does not specifically address codeine cross-reactivity, leaving clinical judgment paramount.